The role of the cannabinoid system in nicotine addiction

被引:52
作者
Castañé, A [1 ]
Berrendero, F [1 ]
Maldonado, R [1 ]
机构
[1] Univ Pompeu Fabra, Fac Ciencies Salut & Vida, Lab Neurofarmacol, Barcelona 08003, Spain
关键词
addiction; cannabinoid; dependence; nicotine; reward; withdrawal;
D O I
10.1016/j.pbb.2005.01.025
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Nicotine, the main psychoactive component in tobacco smoke, appears to play a major role in tobacco addiction, producing a high morbidity and mortality in the world. A great amount of research has been developed to elucidate the neural pathways and neurotransmitter systems involved in such a complex addictive behaviour. One possible candidate is the cannabinoid system, which has been reported to participate in the addictive properties of other drugs of abuse. This review is focused on the recent pharmacological and molecular studies assessing cannabinoid-nicotine interactions, with special attention to those studies evaluating the behavioural responses related to the development of nicotine addiction. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:381 / 386
页数:6
相关论文
共 42 条
[1]  
BARERIO GN, 2004, EUR J NEUROSCI, V20, P2737
[2]   Role of the endocannabinoid system in MDMA intracerebral self-administration in rats [J].
Braida, D ;
Sala, M .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 136 (08) :1089-1092
[3]   Evidence for a new G protein-coupled cannabinoid receptor in mouse brain [J].
Breivogel, CS ;
Griffin, G ;
Di Marzo, V ;
Martin, BR .
MOLECULAR PHARMACOLOGY, 2001, 60 (01) :155-163
[4]   Nicotine addiction: the possible role of functional upregulation [J].
Buisson, B ;
Bertrand, D .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (03) :130-136
[5]   Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence [J].
Castañé, A ;
Valjent, E ;
Ledent, C ;
Parmentier, M ;
Maldonado, R ;
Valverde, O .
NEUROPHARMACOLOGY, 2002, 43 (05) :857-867
[6]   SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats [J].
Cohen, C ;
Perrault, G ;
Voltz, C ;
Steinberg, R ;
Soubrié, P .
BEHAVIOURAL PHARMACOLOGY, 2002, 13 (5-6) :451-463
[7]   Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse [J].
Cossu, G ;
Ledent, C ;
Fattore, L ;
Imperato, A ;
Böhme, GA ;
Parmentier, M ;
Fratta, W .
BEHAVIOURAL BRAIN RESEARCH, 2001, 118 (01) :61-65
[8]   Non-nicotinic neuropharmacological strategies for nicotine dependence: beyond bupropion [J].
Cryan, JF ;
Gasparini, F ;
van Heeke, G ;
Markou, A .
DRUG DISCOVERY TODAY, 2003, 8 (22) :1025-1034
[9]   Characterization of spontaneous and precipitated nicotine withdrawal in the mouse [J].
Damaj, MI ;
Kao, W ;
Martin, BR .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 307 (02) :526-534
[10]   Cellular mechanisms of nicotine addiction [J].
Dani, JA ;
De Biasi, M .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2001, 70 (04) :439-446